Edwards Lifesciences Buys CAS For $100M

Edwards Lifesciences has made its first acquisition since 2017, inking a $100m deal to buy monitoring technology company CAS Medical Systems.

Merging Business Network-Business leaders in global agreement
• Source: shutterstock.com

Edwards Lifesciences Corp. has signed a $100m deal to acquire CAS Medical Systems Inc., the developer of a non-invasive technology for measuring tissue oxygenation in the brain.

Under the terms of the agreement, Edwards will pay $2.45 per share of CAS’ common stock, a 56% premium to...

More from Deals

More from Business